SO-009

Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer

Authors

 

CutsemE Van 1
MachielsJ 2
den EyndeM Van 3
PrenenH 4
HendliszA 5
ShazaL 5
CarrascoJ 6
CanonJ 7
SotiropoulouP 8
BremanE 8
AlcantarE 8
FlamentA 8
University Hospitals Gasthuisberg, Leuven and KU Leuven, Leuven, Belgium

St-Luc University Hospital, Brussels, Belgium Clin. Univ. St-Luc Bruxelles, Brussels, Belgium University Hospital Gasthuisberg, Leuven, Belgium Institut Jules Bordet, Brussels, Belgium Grand Hôpital de Charleroi, Charleroi, Belgium Service d’Oncologie-Hématologie, Grand Hôpital de Charleroi, Charleroi, Belgium Celyad, Mont-Saint-Guibert, Belgium

 

Stay in the know.
OncNet Newsletter